Allulose is shown to boost the production of GLP-1 (glucagon-like peptide-1), PYY (peptide YY), and CCK (cholecystokinin)
To view or add a comment, sign in 370 followers
Removing the first three amino acids reduces its binding to IGF-binding proteins, which normally trap IGF-1 in circulation
Furthermore, ginsenoside Rk1 has been demonstrated to dramatically reduce both VEGF-induced and advanced glycation end products (AGE)-induced retinal endothelial permeability, resulting in reduced retinal edema
It has been studied for its potential healing properties in animal models, showing promise in the repair of various tissues, including muscles, tendons, and bones
While GLP-1 analogues like semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide have shown significant efficacy as standalone treatments for weight management, combining these medications with other weight loss therapies may lead to even more substantial results